Tissue morphometric measurements do not predict survival following colorectal cancer surgery.
CME
CVL and tissue morphometry
Quality of surgery
Journal
World journal of surgical oncology
ISSN: 1477-7819
Titre abrégé: World J Surg Oncol
Pays: England
ID NLM: 101170544
Informations de publication
Date de publication:
22 Aug 2024
22 Aug 2024
Historique:
received:
07
07
2024
accepted:
10
08
2024
medline:
23
8
2024
pubmed:
23
8
2024
entrez:
22
8
2024
Statut:
epublish
Résumé
Ex vivo tissue morphometric (TM) measurements have been proposed as a quality marker for colorectal cancer (CRC) surgery. However, their survival associations require clarification. This study aimed to evaluate the feasibility of capturing TM measurements based on ex vivo fresh specimen images and explore the association between these TM measurements and survival outcomes. A prospective cohort study at Concord Hospital, Sydney was conducted with Stage I to III CRC patients (2009-2019) who underwent an anterior resection (AR) or right hemicolectomy (RH). Using high-resolution digital photographs of fresh CRC specimens, ex vivo tissue morphometric (TM) measurements-resected mesentery area (TM A), distances from high vascular tie to tumour (TM B) and bowel wall (TM C), and bowel length (TM D)-were recorded using Image J. Overall survival (OS) and disease-free survival (DFS) estimates and their associations to clinicopathological variables were investigated with Kaplan-Meier and Cox regression analyses. Linear regression models tested association between TM measurements and lymph node (LN) yield. Of the 1,425 patients who underwent CRC surgery, TM measurements were performed on 312 patients, with an average age of 69.4 years (SD 12.3), of whom 52.9% were male. The majority had an AR (57.8%). Among AR patients, a 5-year OS rate of 77.4% and a DFS rate of 70.1% were observed, with TM measurements bearing no relationship to survival outcomes. Similarly, RH patients exhibited a 5-year OS rate of 67.2% and a DFS rate of 63.1%, with TM measurements again showing no association with survival. Only TM D (P = 0.02) measurements were associated with the number of LNs examined. This study successfully demonstrates the feasibility of measuring TM measurements on photographs of ex vivo fresh specimens following CRC surgery. The lack of association with survival outcomes questions the utility of TM measurements as a quality metric of CRC surgery.
Sections du résumé
BACKGROUND
BACKGROUND
Ex vivo tissue morphometric (TM) measurements have been proposed as a quality marker for colorectal cancer (CRC) surgery. However, their survival associations require clarification. This study aimed to evaluate the feasibility of capturing TM measurements based on ex vivo fresh specimen images and explore the association between these TM measurements and survival outcomes.
METHODS
METHODS
A prospective cohort study at Concord Hospital, Sydney was conducted with Stage I to III CRC patients (2009-2019) who underwent an anterior resection (AR) or right hemicolectomy (RH). Using high-resolution digital photographs of fresh CRC specimens, ex vivo tissue morphometric (TM) measurements-resected mesentery area (TM A), distances from high vascular tie to tumour (TM B) and bowel wall (TM C), and bowel length (TM D)-were recorded using Image J. Overall survival (OS) and disease-free survival (DFS) estimates and their associations to clinicopathological variables were investigated with Kaplan-Meier and Cox regression analyses. Linear regression models tested association between TM measurements and lymph node (LN) yield.
RESULTS
RESULTS
Of the 1,425 patients who underwent CRC surgery, TM measurements were performed on 312 patients, with an average age of 69.4 years (SD 12.3), of whom 52.9% were male. The majority had an AR (57.8%). Among AR patients, a 5-year OS rate of 77.4% and a DFS rate of 70.1% were observed, with TM measurements bearing no relationship to survival outcomes. Similarly, RH patients exhibited a 5-year OS rate of 67.2% and a DFS rate of 63.1%, with TM measurements again showing no association with survival. Only TM D (P = 0.02) measurements were associated with the number of LNs examined.
CONCLUSION
CONCLUSIONS
This study successfully demonstrates the feasibility of measuring TM measurements on photographs of ex vivo fresh specimens following CRC surgery. The lack of association with survival outcomes questions the utility of TM measurements as a quality metric of CRC surgery.
Identifiants
pubmed: 39174976
doi: 10.1186/s12957-024-03496-1
pii: 10.1186/s12957-024-03496-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
216Informations de copyright
© 2024. The Author(s).
Références
Sondenaa K, Quirke P, Hohenberger W, et al. The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis. 2014;29(4):419–28.
doi: 10.1007/s00384-013-1818-2
pubmed: 24477788
Brown KGM, Ng K-S, Solomon MJ, Chapuis PH, Koh CE, Ahmadi N, Austin KKS. Complete mesocolic excision for colon cancer: current status and controversies. ANZ J Surg. 2024;94:309–19. https://doi.org/10.1111/ans.18741 .
West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol. 2010;28(2):272–8.
doi: 10.1200/JCO.2009.24.1448
pubmed: 19949013
West NP, Morris EJ, Rotimi O, Cairns A, Finan PJ, Quirke P. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol. 2008;9(9):857–65.
doi: 10.1016/S1470-2045(08)70181-5
pubmed: 18667357
Almoudaris AM, Clark S, Vincent C, Faiz O. Establishing quality in colorectal surgery. Colorectal Dis. 2011;13(9):961–73.
doi: 10.1111/j.1463-1318.2010.02355.x
pubmed: 20594202
Donabedian A. Evaluating the quality of medical care. 1966. Milbank Q 2005; 83(4): 691–729.
Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373(9666):821–8.
doi: 10.1016/S0140-6736(09)60485-2
pubmed: 19269520
pmcid: 2668948
Ng KS, West NP, Scott N, Holzgang M, Quirke P, Jayne DG. What factors determine specimen quality in colon cancer surgery? A cohort study. Int J Colorectal Dis. 2020;35(5):869–80.
doi: 10.1007/s00384-020-03541-x
pubmed: 32112199
Vogelsang RP, Gogenur M, Dencker D, Bjorn Bennedsen AL, Levin Pedersen D, Gogenur I. Routine CT evaluation of central vascular ligation in patients undergoing complete mesocolic excision for sigmoid colon cancer. Colorectal Dis. 2021;23(8):2030–40.
doi: 10.1111/codi.15723
pubmed: 33974325
Munkedal DL, West NP, Iversen LH, Hagemann-Madsen R, Quirke P, Laurberg S. Implementation of complete mesocolic excision at a university hospital in Denmark: An audit of consecutive, prospectively collected colon cancer specimens. Eur J Surg Oncol. 2014;40(11):1494–501.
doi: 10.1016/j.ejso.2014.04.004
pubmed: 24947074
Newland RC, Chapuis PH, Pheils MT, MacPherson JG. The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases. Cancer. 1981;47(6):1424–9.
doi: 10.1002/1097-0142(19810315)47:6<1424::AID-CNCR2820470630>3.0.CO;2-O
pubmed: 7226068
Newland RC, Chapuis PH, Smyth EJ. The prognostic value of substaging colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer. 1987;60(4):852–7.
doi: 10.1002/1097-0142(19870815)60:4<852::AID-CNCR2820600422>3.0.CO;2-5
pubmed: 3594403
Bokey EL, Chapuis PH, Dent OF, Mander BJ, Bissett IP, Newland RC. Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum. 2003;46(7):860–6.
doi: 10.1007/s10350-004-6673-3
pubmed: 12847357
contributors W. ImageJ. https://en.wikipedia.org/w/index.php?title=ImageJ&oldid=1217807379 . (accessed July 30, 2024.
Dent OF, Newland RC, Chan C, Bokey L, Chapuis PH. Trends in pathology and long-term outcomes after resection of colorectal cancer: 1971–2013. ANZ J Surg. 2017;87(1–2):34–8.
doi: 10.1111/ans.13758
pubmed: 27647676
Naidu K, Chapuis PH, Brown KGM, Chan C, Rickard M, Ng KS. Splenic flexure cancer survival: a 25-year experience and implications for complete mesocolic excision (CME) and central vascular ligation (CVL). ANZ J Surg. 2023;93(7–8):1861–9.
doi: 10.1111/ans.18434
pubmed: 36978261
Adams K, Chapuis PH, Keshava A, et al. Recurrence and colon cancer-specific death in patients with large bowel obstruction requiring urgent operation: a competing risks analysis. Colorectal Dis. 2021;23(10):2604–18.
doi: 10.1111/codi.15807
pubmed: 34252253
Bokey L, Chapuis PH, Chan C, et al. Long-term results following an anatomically based surgical technique for resection of colon cancer: a comparison with results from complete mesocolic excision. Colorectal Dis. 2016;18(7):676–83.
doi: 10.1111/codi.13159
pubmed: 26476136
Steffen C, Bokey EL, Chapuis PH. Carcinoma of the splenic flexure. Dis Colon Rectum. 1987;30(11):872–4.
doi: 10.1007/BF02555427
pubmed: 3677963
Chan CL, Bokey EL, Chapuis PH, Renwick AA, Dent OF. Local recurrence after curative resection for rectal cancer is associated with anterior position of the tumour. Br J Surg. 2006;93(1):105–12.
doi: 10.1002/bjs.5212
pubmed: 16302179
Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol. 1991;6(4):325–44.
doi: 10.1111/j.1440-1746.1991.tb00867.x
pubmed: 1912440
Haboubi N, Berho M. Lymph node harvest (LNH) in colorectal cancer; a critical appraisal. Pol Przegl Chir. 2015;86(10):497–504.
doi: 10.2478/pjs-2014-0089
pubmed: 25720111
Miller ED, Robb BW, Cummings OW, Johnstone PA. The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer. Dis Colon Rectum. 2012;55(9):1002–7.
doi: 10.1097/DCR.0b013e3182536d70
pubmed: 22874609
Mechera R, Schuster T, Rosenberg R, Speich B. Lymph node yield after rectal resection in patients treated with neoadjuvant radiation for rectal cancer: A systematic review and meta-analysis. Eur J Cancer. 2017;72:84–94.
doi: 10.1016/j.ejca.2016.10.031
pubmed: 28027520
Gouvas N, Agalianos C, Papaparaskeva K, Perrakis A, Hohenberger W, Xynos E. Surgery along the embryological planes for colon cancer: a systematic review of complete mesocolic excision. Int J Colorectal Dis. 2016;31(9):1577–94.
doi: 10.1007/s00384-016-2626-2
pubmed: 27469525
Siani LM, Pulica C. Laparoscopic complete mesocolic excision with central vascular ligation in right colon cancer: Long-term oncologic outcome between mesocolic and non-mesocolic planes of surgery. Scand J Surg. 2015;104(4):219–26.
doi: 10.1177/1457496914557017
pubmed: 25391978
Storli KE, Sondenaa K, Furnes B, et al. Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I-II. Tech Coloproctol. 2014;18(6):557–64.
doi: 10.1007/s10151-013-1100-1
pubmed: 24357446
Galizia G, Lieto E, De Vita F, et al. Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers? A prospective study. Int J Colorectal Dis. 2014;29(1):89–97.
doi: 10.1007/s00384-013-1766-x
pubmed: 23982425
West NP, Kobayashi H, Takahashi K, et al. Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol. 2012;30(15):1763–9.
doi: 10.1200/JCO.2011.38.3992
pubmed: 22473170
Kobayashi H, West NP. CME versus D3 Dissection for Colon Cancer. Clin Colon Rectal Surg. 2020;33(6):344–8.
doi: 10.1055/s-0040-1714237
pubmed: 33162838
pmcid: 7605910
Kobayashi H, West NP, Takahashi K, et al. Quality of surgery for stage III colon cancer: comparison between England, Germany, and Japan. Ann Surg Oncol. 2014;21(Suppl 3):S398-404.
doi: 10.1245/s10434-014-3578-9
pubmed: 24566862
Sadahiro S, Ohmura T, Yamada Y, Saito T, Taki Y. Analysis of length and surface area of each segment of the large intestine according to age, sex and physique. Surg Radiol Anat. 1992;14(3):251–7.
doi: 10.1007/BF01794949
pubmed: 1440190
Yoshida M, Ishiguro M, Ikejiri K, et al. S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial). Ann Oncol. 2014;25(9):1743–9.
doi: 10.1093/annonc/mdu232
pubmed: 24942277
pmcid: 4143094
Shimada Y, Hamaguchi T, Mizusawa J, et al. Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205. Eur J Cancer. 2014;50(13):2231–40.
doi: 10.1016/j.ejca.2014.05.025
pubmed: 24958736